Forth Therapeutics is a biotechnology company developing precision therapeutics for fibrosis using advanced omics technology and a significant single-cell human liver disease dataset.

uFraction8 develops microfluidics-based filter systems to improve productivity for bio-manufacturers with energy-efficient and scalable perfusion systems.

Concinnity is a biotech company that uses AI-driven RNA-based systems to enhance the safety of gene therapies.

Cytomos is a biotechnology company that develops scalable cell-analysis technology to provide cost-effective solutions for biopharma companies.

Invizius is a biotech company developing H-Guard, a product designed to reduce inflammatory responses in dialysis and ICU patients undergoing continuous renal replacement therapy.

Neuranics develops magnetic sensors integrated with semiconductor technology for health, fitness, and metaverse applications, aiming to improve health monitoring devices and human-machine interfaces.

Neuranics develops magnetic sensors integrated with semiconductor technology for health, fitness, and metaverse applications, aiming to improve health monitoring devices and human-machine interfaces.

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.